Global and United States Cholera Vaccines Market Report & Forecast 2023-2028

Report ID: 1835330 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Cholera Vaccines Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Cholera Vaccines Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cholera Vaccines Market Size for the Year 2017-2028
        1.2.2 Global Cholera Vaccines Market Size for the Year 2017-2028
    1.3 Cholera Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Cholera Vaccines in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Cholera Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Cholera Vaccines Market Dynamics
        1.4.1 Cholera Vaccines Industry Trends
        1.4.2 Cholera Vaccines Market Drivers
        1.4.3 Cholera Vaccines Market Challenges
        1.4.4 Cholera Vaccines Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Cholera Vaccines by Type
    2.1 Cholera Vaccines Market Segment by Type
        2.1.1 Dukoral
        2.1.2 Shanchol
        2.1.3 Vaxchora
        2.1.4 Others
    2.2 Global Cholera Vaccines Market Size by Type (2017, 2022 & 2028)
    2.3 Global Cholera Vaccines Market Size by Type (2017-2028)
    2.4 United States Cholera Vaccines Market Size by Type (2017, 2022 & 2028)
    2.5 United States Cholera Vaccines Market Size by Type (2017-2028)
3 Cholera Vaccines by Application
    3.1 Cholera Vaccines Market Segment by Application
        3.1.1 Oral
        3.1.2 Others
    3.2 Global Cholera Vaccines Market Size by Application (2017, 2022 & 2028)
    3.3 Global Cholera Vaccines Market Size by Application (2017-2028)
    3.4 United States Cholera Vaccines Market Size by Application (2017, 2022 & 2028)
    3.5 United States Cholera Vaccines Market Size by Application (2017-2028)
4 Global Cholera Vaccines Competitor Landscape by Company
    4.1 Global Cholera Vaccines Market Size by Company
        4.1.1 Top Global Cholera Vaccines Companies Ranked by Revenue (2021)
        4.1.2 Global Cholera Vaccines Revenue by Player (2017-2022)
    4.2 Global Cholera Vaccines Concentration Ratio (CR)
        4.2.1 Cholera Vaccines Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Cholera Vaccines in 2021
        4.2.3 Global Cholera Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cholera Vaccines Headquarters, Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Cholera Vaccines Headquarters and Area Served
        4.3.2 Global Cholera Vaccines Companies Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Cholera Vaccines Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Cholera Vaccines Market Size by Company
        4.5.1 Top Cholera Vaccines Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cholera Vaccines Revenue by Players (2020, 2021 & 2022)
5 Global Cholera Vaccines Market Size by Region
    5.1 Global Cholera Vaccines Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cholera Vaccines Market Size by Region (2017-2028)
        5.2.1 Global Cholera Vaccines Market Size by Region: 2017-2022
        5.2.2 Global Cholera Vaccines Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cholera Vaccines Market Size YoY Growth 2017-2028
        6.1.2 North America Cholera Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cholera Vaccines Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cholera Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Cholera Vaccines Market Size YoY Growth 2017-2028
        6.3.2 Europe Cholera Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cholera Vaccines Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cholera Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cholera Vaccines Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cholera Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Shantha Biotechnics Private Limited
        7.1.1 Shantha Biotechnics Private Limited Company Details
        7.1.2 Shantha Biotechnics Private Limited Business Overview
        7.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Introduction
        7.1.4 Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2017-2022)
        7.1.5 Shantha Biotechnics Private Limited Recent Development
    7.2 PaxVax, Inc.
        7.2.1 PaxVax, Inc. Company Details
        7.2.2 PaxVax, Inc. Business Overview
        7.2.3 PaxVax, Inc. Cholera Vaccines Introduction
        7.2.4 PaxVax, Inc. Revenue in Cholera Vaccines Business (2017-2022)
        7.2.5 PaxVax, Inc. Recent Development
    7.3 Valneva SE
        7.3.1 Valneva SE Company Details
        7.3.2 Valneva SE Business Overview
        7.3.3 Valneva SE Cholera Vaccines Introduction
        7.3.4 Valneva SE Revenue in Cholera Vaccines Business (2017-2022)
        7.3.5 Valneva SE Recent Development
    7.4 Merck and Co., Inc.
        7.4.1 Merck and Co., Inc. Company Details
        7.4.2 Merck and Co., Inc. Business Overview
        7.4.3 Merck and Co., Inc. Cholera Vaccines Introduction
        7.4.4 Merck and Co., Inc. Revenue in Cholera Vaccines Business (2017-2022)
        7.4.5 Merck and Co., Inc. Recent Development
    7.5 GlaxoSmithKline plc (GSK)
        7.5.1 GlaxoSmithKline plc (GSK) Company Details
        7.5.2 GlaxoSmithKline plc (GSK) Business Overview
        7.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Introduction
        7.5.4 GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2017-2022)
        7.5.5 GlaxoSmithKline plc (GSK) Recent Development
    7.6 Astellas Pharma, Inc.
        7.6.1 Astellas Pharma, Inc. Company Details
        7.6.2 Astellas Pharma, Inc. Business Overview
        7.6.3 Astellas Pharma, Inc. Cholera Vaccines Introduction
        7.6.4 Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2017-2022)
        7.6.5 Astellas Pharma, Inc. Recent Development
    7.7 Pfizer, Inc.
        7.7.1 Pfizer, Inc. Company Details
        7.7.2 Pfizer, Inc. Business Overview
        7.7.3 Pfizer, Inc. Cholera Vaccines Introduction
        7.7.4 Pfizer, Inc. Revenue in Cholera Vaccines Business (2017-2022)
        7.7.5 Pfizer, Inc. Recent Development
    7.8 Emergent BioSolutions, Inc.
        7.8.1 Emergent BioSolutions, Inc. Company Details
        7.8.2 Emergent BioSolutions, Inc. Business Overview
        7.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Introduction
        7.8.4 Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2017-2022)
        7.8.5 Emergent BioSolutions, Inc. Recent Development
    7.9 Mitsubishi Tanabe Pharma Corporation
        7.9.1 Mitsubishi Tanabe Pharma Corporation Company Details
        7.9.2 Mitsubishi Tanabe Pharma Corporation Business Overview
        7.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Introduction
        7.9.4 Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2017-2022)
        7.9.5 Mitsubishi Tanabe Pharma Corporation Recent Development
    7.10 Takeda Pharmaceutical Co., Ltd.
        7.10.1 Takeda Pharmaceutical Co., Ltd. Company Details
        7.10.2 Takeda Pharmaceutical Co., Ltd. Business Overview
        7.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Introduction
        7.10.4 Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2017-2022)
        7.10.5 Takeda Pharmaceutical Co., Ltd. Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Cholera Vaccines Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cholera Vaccines Market Trends
    Table 3. Cholera Vaccines Market Drivers
    Table 4. Cholera Vaccines Market Challenges
    Table 5. Cholera Vaccines Market Restraints
    Table 6. Global Cholera Vaccines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cholera Vaccines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cholera Vaccines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cholera Vaccines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cholera Vaccines Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cholera Vaccines Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cholera Vaccines Revenue Share by Player, 2017-2022
    Table 13. Global Cholera Vaccines Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cholera Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholera Vaccines as of 2021)
    Table 15. Top Players of Cholera Vaccines in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cholera Vaccines Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cholera Vaccines Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cholera Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cholera Vaccines Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cholera Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cholera Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cholera Vaccines Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cholera Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cholera Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cholera Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cholera Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cholera Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Shantha Biotechnics Private Limited Company Details
    Table 31. Shantha Biotechnics Private Limited Business Overview
    Table 32. Shantha Biotechnics Private Limited Cholera Vaccines Product
    Table 33. Shantha Biotechnics Private Limited Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 34. Shantha Biotechnics Private Limited Recent Development
    Table 35. PaxVax, Inc. Company Details
    Table 36. PaxVax, Inc. Business Overview
    Table 37. PaxVax, Inc. Cholera Vaccines Product
    Table 38. PaxVax, Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 39. PaxVax, Inc. Recent Development
    Table 40. Valneva SE Company Details
    Table 41. Valneva SE Business Overview
    Table 42. Valneva SE Cholera Vaccines Product
    Table 43. Valneva SE Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 44. Valneva SE Recent Development
    Table 45. Merck and Co., Inc. Company Details
    Table 46. Merck and Co., Inc. Business Overview
    Table 47. Merck and Co., Inc. Cholera Vaccines Product
    Table 48. Merck and Co., Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 49. Merck and Co., Inc. Recent Development
    Table 50. GlaxoSmithKline plc (GSK) Company Details
    Table 51. GlaxoSmithKline plc (GSK) Business Overview
    Table 52. GlaxoSmithKline plc (GSK) Cholera Vaccines Product
    Table 53. GlaxoSmithKline plc (GSK) Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 54. GlaxoSmithKline plc (GSK) Recent Development
    Table 55. Astellas Pharma, Inc. Company Details
    Table 56. Astellas Pharma, Inc. Business Overview
    Table 57. Astellas Pharma, Inc. Cholera Vaccines Product
    Table 58. Astellas Pharma, Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 59. Astellas Pharma, Inc. Recent Development
    Table 60. Pfizer, Inc. Company Details
    Table 61. Pfizer, Inc. Business Overview
    Table 62. Pfizer, Inc. Cholera Vaccines Product
    Table 63. Pfizer, Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 64. Pfizer, Inc. Recent Development
    Table 65. Emergent BioSolutions, Inc. Company Details
    Table 66. Emergent BioSolutions, Inc. Business Overview
    Table 67. Emergent BioSolutions, Inc. Cholera Vaccines Product
    Table 68. Emergent BioSolutions, Inc. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 69. Emergent BioSolutions, Inc. Recent Development
    Table 70. Mitsubishi Tanabe Pharma Corporation Company Details
    Table 71. Mitsubishi Tanabe Pharma Corporation Business Overview
    Table 72. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product
    Table 73. Mitsubishi Tanabe Pharma Corporation Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 74. Mitsubishi Tanabe Pharma Corporation Recent Development
    Table 75. Takeda Pharmaceutical Co., Ltd. Company Details
    Table 76. Takeda Pharmaceutical Co., Ltd. Business Overview
    Table 77. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product
    Table 78. Takeda Pharmaceutical Co., Ltd. Revenue in Cholera Vaccines Business (2017-2022) & (US$ Million)
    Table 79. Takeda Pharmaceutical Co., Ltd. Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cholera Vaccines Product Picture
    Figure 2. Global Cholera Vaccines Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cholera Vaccines Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cholera Vaccines Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cholera Vaccines Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cholera Vaccines Market Share in Global 2017-2028
    Figure 7. Cholera Vaccines Report Years Considered
    Figure 8. Product Picture of Dukoral
    Figure 9. Product Picture of Shanchol
    Figure 10. Product Picture of Vaxchora
    Figure 11. Product Picture of Others
    Figure 12. Global Cholera Vaccines Market Share by Type in 2022 & 2028
    Figure 13. Global Cholera Vaccines Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Cholera Vaccines Market Share by Type (2017-2028)
    Figure 15. United States Cholera Vaccines Market Share by Type in 2022 & 2028
    Figure 16. United States Cholera Vaccines Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Cholera Vaccines Market Share by Type (2017-2028)
    Figure 18. Product Picture of Oral
    Figure 19. Product Picture of Others
    Figure 20. Global Cholera Vaccines Market Share by Application in 2022 & 2028
    Figure 21. Global Cholera Vaccines Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Cholera Vaccines Market Share by Application (2017-2028)
    Figure 23. United States Cholera Vaccines Market Share by Application in 2022 & 2028
    Figure 24. United States Cholera Vaccines Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Cholera Vaccines Market Share by Application (2017-2028)
    Figure 26. North America Cholera Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Cholera Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Cholera Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Cholera Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Cholera Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Cholera Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Shantha Biotechnics Private Limited Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 55. PaxVax, Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 56. Valneva SE Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 57. Merck and Co., Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 58. GlaxoSmithKline plc (GSK) Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 59. Astellas Pharma, Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 60. Pfizer, Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 61. Emergent BioSolutions, Inc. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 62. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 63. Takeda Pharmaceutical Co., Ltd. Revenue Growth Rate in Cholera Vaccines Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck and Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Frequently Asked Questions
Cholera Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cholera Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cholera Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports